TREATMENT ADHERENCE AND QUALITY OF LIFE OF PATIENTS WITH STABLE ISCHEMIC HEART DISEASE IN TREATMENT WITH NICORANDIL: INTERRELATION AND INTERACTION (ACCORDING TO THE RESULTS OF THE OBSERVATIONAL STUDY NIKEA)

Aim. To assess quality of life (QoL) and its dynamics during nicorandil treatment in patients with stable ischemic heart disease, to study the relationship of treatment adherence and QoL indicators when treated with nicorandil.

Material and methods. Observational program NIKEA included 590 patients with angina pectoris. Seattle Angina Questionnaire (SAQ) was used to assess QoL. Patients completed SAQ at the visit of inclusion (V0) and at the visit after 3 months of observation (V3). Potential and actual adherence to therapy was assessed by medical interviews at visits V0, V1 (1 month of observation) and V3. During the visit V0 417 people (from 590 ones enrolled into the study) completed SAQ (71% response); after 3 months (V3) SAQ was filled in by 454 of 552 people who came to this visit (82% response). According to the results of medical interviews, potential adherence (visit V0) was determined in all 590 patients, actual adherence to nicorandil (visits V1 and V3) was assessed in 552 patients who came to these visits. In accordance with the degree of adherence, all patients were divided into 3 groups: (1) adherent to treatment (taking nicorandil for the first three months), (2) non-adherent (who refused to take nicorandil), and (3) partially non-adherent (who started nicorandil, but for various reasons stopped taking the drug).

Results. In all patients, regardless of their adherence to the recommended drug, there was an increase in QoL according to all five scales of the SAQ after 3 months of follow-up. Statistically significant positive dynamics of all SAQ indicators was found only in adherent patients (p<0.0001 for all aspects). Patients, who showed good adherence to nicorandil at V1, had more severe angina at the beginning of treatment (according to “Angina Stability” and “Angina Frequency” indicators). These patients also had lower QoL “Disease Perception” score and more confidence in the doctor (“Treatment Satisfaction” score) than non-adherent patients (p<0.05). In non-adherent patients a mild degree of angina was determined 2 times more often according to “Angina Frequency” indicator (p=0.03).

Conclusion. The results of the study confirm the interrelation and mutual influence of the QoL indicators and treatment adherence to nicorandil. Effective treatment with nicorandil in patients with lower health-related QoL indicators could increase treatment adherence. On the other hand, the mild degree of angina, the low level of confidence in the treating doctor, the side effects of the new drug reduce medication adherence of patients, which, as a result, negatively affects the QoL of these patients

1. Haynes R.B., McDonald H., Garg A.X., Montague P. Interventions for helping patients to follow prescriptions for medications. Send to Cochrane Database Syst Rev. 2002;(2):CD000011. doi: 10.1002/14651858.CD000011.

2. Hsu C., Lemon J.M., Wong E.S. et al. Factors affecting medication adherence: Patient perspective from five veterans affairs facilities. BMC Health Services Research. 2014;14:533-41.

3. Alhaddad I.A., Hamoui O., Hammoudeh A., Mallat S. Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence. Vasc Health Risk Manag. 2016; 27(12):407-13. doi:10.2147/VHRM.S105921.

4. Perwitasari D.A., Urbayatun S. Treatment Adherence and Quality of Life in Diabetes Mellitus Patients in Indonesia. SAGE Open. 2016:1-7. doi: 10.1177/2158244016643748.

5. Zioga E., Kazakos K., Dimopoulos E. et al. Adherence and quality of life in patients with type 2 diabetes mellitus in northern Greece. Mater Sociomed. 2016;28(4):258-62. doi: 10.5455/msm. 2016.28.258-262.

6. Martínez Y.V., Prado-Aguilar C.A., Rascón-Pacheco R.A., Valdivia-Martínez J.J. Quality of life associated with treatment adherence in patients with type 2 diabetes: a cross-sectional study. BMC Health Serv Res. 2008;30(8):164. doi: 10.1186/1472-6963-8-164.

7. Cote I., Farris K., Feeny D. Is adherence to drug treatment correlated with health-related quality of life? Quality of Life Research. 2003;12(6):621-33.

8. Martsevich S.Y., Lukina Y.V., Kutishenko N.P. et al. Observational, multi-center study of the use of nicorandil in patients with stable ischemic heart disease with high cardiovascular risk (NIKEA): design, first results. Russian Cardiology Journal. 2017;9(149):75-82. (In Russ.) [Марцевич С.Ю., Лукина Ю.В., Кутишенко Н.П. и др. Наблюдательное многоцентровое исследование применения никорандила у больных стабильной ишемической болезнью сердца с высоким сердечно-сосудистым риском (НИКЕЯ): дизайн, первые результаты. Российский Кардиологический Журнал. 2017;9(149):75-82].

9. Martsevich S.Y., Lukina Y.V., Kutishenko N.P. et al. Changes in the quality of life in the use of nicorandil in patients with stable coronary heart disease (the results of the observational program "NIKEA", Cardiovascular Therapy and Prevention. 2017;16(6):57-64 (In Russ.) [Марцевич С.Ю., Лукина Ю.В., Кутишенко Н.П. и др. Изменение показателей качества жизни при применении никорандила у больных стабильной ишемической болезнью сердца (результаты наблюдательной программы НИКЕЯ. Кардиоваскулярная Терапия и Профилактика. 2017;16(6):57-64. doi: 10.15829/1728- 8800-2017-6-57-64.

10. Martsevich S.Y., Lukina Y.V., Kutishenko N.P. et al. Assessment of adherence to treatment and factors affecting it, in patients with stable coronary heart disease in the appointment of nicorandil. Rational Pharmacotherapy in Cardiology. 2017;13(6):776-86. (In Russ.) [Марцевич С.Ю., Лукина Ю.В., Кутишенко Н.П. и др. Оценка приверженности к лечению и факторов, влияющих на нее, у пациентов со стабильной ишемической болезнью сердца при назначении никорандила. Рациональная Фармакотерапия в Кардиологии. 2017;13(6):776-86. doi: 10.20996/1819- 6446-2017-13-6-776-786.

11. Spertus J.A., Winder J.A., Dewhurst T.A. et al. Monitoring the quality of life in patients with coronary artery disease. Am J Cardiol. 1994;74:1240-4. doi: 10.1016/0002-9149(94)90555-X.

12. Spertus J.A., Jones P., McDonell M. et al. Health status predicts long-term outcome in outpatients with coronary artery disease. Circulation. 2002;106:43-9. doi: 10.1161/01.CIR.000002 0688.24874.90.

13. Beinart S.C., Sales A.E., Spertus J.A. et al. Impact of angina burden and other factors on treatment satisfaction after acute coronary syndromes. Am Heart J. 2003;146:646-52. doi: 10.1016/S0002- 8703(03)00256-4.

14. Saleh F., Mumu S.J., Ara F. et al. Non-adherence to self-care practices & medication and health related quality of life among patients with type 2 diabetes: A cross-sectional study. BMC Public Health. 2014;14:431. doi: 10.1186/1471-2458-14-431.

15. Semenova Y.V., Kutishenko N.P., Martsevich S.Y. Analysis of the problem of low adherence of patients to attendance at outpatient clinics and cardiorehabilitation programs according to the data from published studies. Rational Pharmacotherapy in Cardiology. 2015;11(6):618-25. (In Russ.) [Семенова Ю.В., Кутишенко Н.П., Марцевич С.Ю. Анализ проблемы низкой приверженности пациентов к посещению амбулаторных учреждений и программ кардиореабилитации по данным опубликованных исследований. Рациональная Фармакотерапия в Кардиологии. 2015;11(6):618- 25]. doi: 10.20996/1819-6446-2015-11-6-618-625.

16. Martsevich S.Y., Gaysenok O.V., Tripkosh S.G. et al. Medical supervision in specialized center and the quality of lipid-lowering therapy in patients with cardiovascular diseases (according to the PROFILE register). Rational Pharmacotherapy in Cardiology. 2013;9(2):133-7. (In Russ.) [Марцевич С.Ю., Гайсенок О.В., Трипкош С.Г. и др. Наблюдение в специализированном медицинском центре и качество гиполипидемической терапии у пациентов с сердечно-сосудистыми заболеваниями (по данным регистра ПРОФИЛЬ). Рациональная Фармакотерапия в Кардиологии. 2013;9(2):133-7. doi: 10.20996/1819-6446-2013-9-2-133-137.

17. Lukina Y.V., Kutishenko N.P., Dmitrieva N.A., Martsevich S.Y. Adherence of patients with chronic ischemic heart disease to medical recommendations (according to the outpatient register PROFILE). Russian Cardiology Journal. 2017;2(142):14-9. (In Russ.) [Лукина Ю.В., Кутишенко Н.П., Дмитриева Н.А., Марцевич С.Ю. Приверженность больных хронической ишемической болезнью сердца к врачебным рекомендациям (по данным амбулаторного регистра ПРОФИЛЬ). Российский Кардиологический Журнал. 2017;2(142):14-9].

18. Kosheleva N.A., Rebrov A.P. Quality of life and prognosis for different approaches to management of patients with chronic heart failure. Modern problems of science and education, 2011;5. [cited by Jun 20, 2018]. Available from:http://www.science-education.ru/ru/article/view?id=4850. (In Russ.) [Кошелева Н.А., Ребров А.П. Качество жизни и прогноз при различных подходах к ведению больных хронической сердечной недостаточностью. Современные Проблемы Науки и Образования. 2011;5. [цитировано 20.06.2018]. Доступно на:http://www.scienceeducation.ru/ru/article/view?id=4850.

19. De Souza ACC, Borges JWP, Moreira TMM. Quality of life and treatment adherence in hypertensive patients: systematic review with meta-analysis. Revista de Saúde Pública. 2016;50:71. doi: 10.1590/S1518-8787.2016050006415.

20. Claxton A.J., Cramer J., Pierce C.A. Systematic review of the associations between dose regimens and medication compliance. Clinical Therapeutic. 2001;23:1296-310.

21. Lukina Y.V., Ginzburg M.L., Smirnov V.P. et al. Assessing factors that form patient’s attitude to treatment preceding hospitalization for acute coronary syndrome (data of questionnaire within the LIS register). Rational Pharmacotherapy in Cardiology. 2013;9(5):472-81. (In Russ.) [Лукина Ю.В., Гинзбург М.Л., Смирнов В.П. и соавт Изучение факторов, формирующих отношение пациента к лечению, предшествовавшему госпитализации по поводу острого коронарного синдрома (данные анкетирования в рамках регистра ЛИС). Рациональная Фармакотерапия в Кардиологии. 2013; 9(5):472-81]. doi: 10.20996/1819-6446-2013-9-5-472-481.

22. Chao J., Nau D.P., Aikens J.E. Recommendations for improving adherence to type 2 diabetes mellitus therapy focus on optimizing oral and non-insulin therapies. American Journal of Managed Care. 2012;18:S49-S54.

23. Lukina Y.V., Dmitrieva N.A., Zakharova A.V. et al. Adverse event of drug therapy (the first results of the study according to the PROFILE outpatient register). Rational Pharmacotherapy in Cardiology. 2016;12(3):306-13. (In Russ.) [Лукина Ю.В., Дмитриева Н.А., Захарова А.В. и соавт. Нежелательные явления лекарственной терапии (первые результаты исследования по данным амбулаторного регистра ПРОФИЛЬ). Рациональная Фармакотерапия в Кардиологии. 2016;12(3):306-13]. doi: 10.20996/1819-6446-2016-12-3-306-313.